Solventum Corp | SOLV - Sales Revenues

Stock Price
69.78
Daily Change
1.26 1.84%
Monthly
9.98%
Yearly
5.62%
Q2 Forecast
67.05

Solventum Corp reported $1.99B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Align Technology USD 1.05B 54.3M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Cencora USD 85.93B 32.02M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Solventum Corp USD 1.99B 110M Dec/2025
West Pharmaceutical Services USD 844.9M 39.9M Mar/2026
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025